NEW DEVELOPMENTS IN PRICING AND DRUG REIMBURSEMENT IN FRANCE

被引：6
|
作者：
PELC, A
CASTAN, JP
机构：
[1] IMS Health Economics, Paris, 92542, 85, rue Gabriel Peri, Montrouge
[2] Carré Castan Consultants, Paris
来源：
PHARMACOECONOMICS | 1994年 / 6卷
关键词：
D O I：
10.2165/00019053-199400061-00009
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
In this article, we review the current French price reimbursement scheme and how this scheme is affected by a new decree published in 1993, or will be affected by this decision already announced but not yet implemented. France has been perceived as a pioneering country regarding the attitude of the Health Authority towards pharmacoeconomics. Here, we describe the present status afforded such studies in the price reimbursement scheme. Finally, we discuss the possible impact of the national agreement between physicians and statutory Health Funds on the pharmaceutical industry in France.
引用
收藏
页码：28 / 35
页数：8
相关论文
共 50 条
  • [1] Drug pricing and reimbursement in France - Towards a new model?
    LePen, C
    [J]. PHARMACOECONOMICS, 1996, 10 : 26 - 36
  • [2] Pricing and reimbursement of innovative pharmaceuticals in France and the new healthcare reform
    Natz, Alexander
    Campion, Marie-Genevieve
    [J]. FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2012, 13 (02) : 49 - 60
  • [3] Pricing and reimbursement of pharmaceutical products in France
    Friedeberg-Steward, B
    [J]. DRUG INFORMATION JOURNAL, 2000, 34 (04): : 1201 - 1205
  • [4] Pricing and Reimbursement of Pharmaceutical Products in France
    Beatrix Friedeberg-Steward
    [J]. Drug information journal : DIJ / Drug Information Association, 2000, 34 (4): : 1201 - 1205
  • [5] ANALYSIS OF THE REIMBURSEMENT AND PRICING OF HYBRID MEDICINES IN FRANCE
    Gaugy, P.
    Cottin, J.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S345 - S345
  • [6] DRUG PRICING AND REIMBURSEMENT PROCESSES IN ALGERIA
    Soualmi, R.
    Bouabidi, A.
    Djahdou, Z.
    Ziouani, S.
    Kaddar, M.
    Mansouri, K.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A448 - A449
  • [7] KEY DRIVERS FOR PRICING AND REIMBURSEMENT FOR BIOLOGIC DRUGS IN FRANCE
    Niklitschek, T.
    Williams, A. E.
    Storer, M.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A452 - A452
  • [8] Reimbursement and Pricing of Drugs in France An increasingly complex system
    F. Pelen
    [J]. HEPAC Health Economics in Prevention and Care, 2000, 0 (0): : 20 - 23
  • [9] Will there ever be a European drug pricing and reimbursement agency?
    M. F. Drummond
    [J]. The European Journal of Health Economics, 2003, 4 (2) : 67 - 69
  • [10] Drug pricing and reimbursement decision making systems in Mongolia
    Dorj G.
    Sunderland B.
    Sanjjav T.
    Dorj G.
    Gendenragchaa B.
    [J]. Journal of Pharmaceutical Policy and Practice, 10 (1)
12345